Spyre Therapeutics, Inc. - SYRE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$4.314B
QoQ value delta ($000)
+$1.353B (+45.72%)
Implied price effect (QoQ)
+36.33%
Shares
Total shares
87,068,196
QoQ shares delta
+5,608,912 (+6.89%)
Total shares held by funds (by quarter)

Market chart (SYRE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 199 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 594,234 11,781,024 0.03%
BlackRock, Inc. 278,490 5,521,221 0.0%
RTW INVESTMENTS, LP 210,435 4,171,996 2.09%
Fairmount Funds Management LLC 202,673 4,018,101 14.64%
PERCEPTIVE ADVISORS LLC 190,825 3,783,225 3.73%
Venrock Adviser, LLC 185,893 3,685,448 6.94%
VANGUARD CAPITAL MANAGEMENT LLC 154,215 3,057,401 0.0%
DRIEHAUS CAPITAL MANAGEMENT LLC 140,767 2,790,785 1.03%
VANGUARD GROUP INC 132,189 4,035,074 0.0%
STATE STREET CORP 131,498 2,607,031 0.0%
Paradigm Biocapital Advisors LP 98,724 1,957,266 2.02%
Commodore Capital LP 96,460 1,912,380 5.58%
TCG Crossover Management, LLC 95,865 1,900,582 2.74%
TANG CAPITAL MANAGEMENT LLC 95,442 1,892,200 4.85%
WELLINGTON MANAGEMENT GROUP LLP 92,043 1,824,811 0.02%
Capital International Investors 88,074 1,746,129 0.02%
GEODE CAPITAL MANAGEMENT, LLC 86,819 1,720,912 0.01%
JANUS HENDERSON GROUP PLC 83,586 1,656,164 0.04%
RA CAPITAL MANAGEMENT, L.P. 81,794 1,621,620 0.87%
PRICE T ROWE ASSOCIATES INC /MD/ 80,641 1,598,730 0.01%
Remedium Capital Partners, LLC 73,452 1,456,231 26.13%
Affinity Asset Advisors, LLC 64,519 1,279,134 3.33%
BANK OF AMERICA CORP /DE/ 61,945 1,228,093 0.0%
BAKER BROS. ADVISORS LP 50,440 1,000,000 0.29%
BRAIDWELL LP 47,051 932,823 1.57%